Trileptal

Trileptal is a brand name of oxcarbazepine, approved by the FDA in the following formulation(s):

TRILEPTAL (oxcarbazepine - suspension; oral)

• 
  Manufacturer: NOVARTIS
  
  Approval date: May 25, 2001
  
  Strength(s): 300MG/5ML ^[RLD][AB]

TRILEPTAL (oxcarbazepine - tablet; oral)

• 
  Manufacturer: NOVARTIS
  
  Approval date: January 14, 2000
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[RLD][AB]

Has a generic version of Trileptal been approved?

A generic version of Trileptal has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Trileptal and have been approved by the FDA:

oxcarbazepine suspension; oral

• 
  Manufacturer: RANBAXY
  
  Approval date: June 26, 2009
  
  Strength(s): 300MG/5ML ^[AB]

oxcarbazepine tablet; oral

• 
  Manufacturer: APOTEX INC
  
  Approval date: April 9, 2008
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[AB]


• 
  Manufacturer: BRECKENRIDGE PHARM
  
  Approval date: January 11, 2008
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[AB]


• 
  Manufacturer: CADISTA PHARMS
  
  Approval date: January 25, 2010
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: October 9, 2007
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: October 9, 2007
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[AB]


• 
  Manufacturer: SUN PHARM INDS
  
  Approval date: October 9, 2007
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: November 15, 2007
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[AB]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: December 11, 2007
  
  Strength(s): 150MG ^[AB], 300MG ^[AB], 600MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Trileptal. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Oxacarbazepine film-coated tablets
  Patent 7,037,525
  Issued: May 2, 2006
  Inventor(s): Schlütermann; Burkhard
  Assignee(s): Novartis AG
  The invention relates to formulations, e.g. film-coated tablets containing oxcarbazepine and to processes for the production of said formulations. The film-coated tablets have a tablet core comprising a therapeutically effective dose of oxacarbazepine being in a finely ground form having a mean particle size of from 4 to 12 μm (median value), and a hydrophilic permeable outer coating.
  
  Patent expiration dates:
  
  
  • February 12, 2018
    
    ✓ 
    Patent use: METHOD OF TREATING SEIZURES
  
  
  
  • August 12, 2018
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Trileptal Consumer Information (Drugs.com)
• Trileptal Consumer Information (Wolters Kluwer)
• Trileptal Suspension Consumer Information (Wolters Kluwer)
• Trileptal Consumer Information (Cerner Multum)
• Trileptal Advanced Consumer Information (Micromedex)
• Trileptal AHFS DI Monographs (ASHP)
• Oxcarbazepine Consumer Information (Wolters Kluwer)
• Oxcarbazepine Suspension Consumer Information (Wolters Kluwer)
• Oxcarbazepine Consumer Information (Cerner Multum)
• Oxcarbazepine Advanced Consumer Information (Micromedex)
• Oxcarbazepine AHFS DI Monographs (ASHP)